World Health Organization. Global HIV programme. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statistics. Accessed 15 Mar 2023.
GBD 2017 HIV collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6:e831–e859. https://doi.org/10.1016/S2352-3018(19)30196-1.
UNAIDS. Global HIV & AIDS statistics — Fact sheet. https://www.unaids.org/en/resources/fact-sheet [Accessed June 28, 2023]
UNAIDS. In danger: UNAIDS global AIDS update 2022. Geneva: Joint United Nations Programme on HIV/AIDS (2022). https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update-summary_en.pdf. Accessed 16 Mar 2023.
Waterfield KC, Shah GH, Etheredge GD, Ikhile O. Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health. BMC Public Health. 2021;21:299. https://doi.org/10.1186/s12889-021-10296-9.
Article CAS PubMed PubMed Central Google Scholar
Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. HIV-associated neurocognitive disorder–pathogenesis and prospects for treatment. Nat Rev Neurol. 2016;12:234–48. https://doi.org/10.1038/nrneurol.2016.27.
Article PubMed PubMed Central Google Scholar
Balaji S, Chakraborty R, Aggarwal S. Neurological complications caused by human immunodeficiency virus (HIV) and associated opportunistic co-infections: a review on their diagnosis and therapeutic insights. CNS Neurol Disord Drug Targets. 2023. https://doi.org/10.2174/1871527322666230330083708.
Roomaney RA, van Wyk B, Pillay-van WV. Aging with HIV: increased risk of HIV comorbidities in older adults. Int J Environ Res Public Health. 2022;19:2359. https://doi.org/10.3390/ijerph19042359.
Article PubMed PubMed Central Google Scholar
Gesesew HA, Tesfay Gebremedhin A, Demissie TD, Kerie MW, Sudhakar M, Mwanri L. Significant association between perceived HIV related stigma and late presentation for HIV/AIDS care in low and middle-income countries: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0173928. https://doi.org/10.1371/journal.pone.0173928.
Article CAS PubMed PubMed Central Google Scholar
World Health Organization, African Region. HIV/AIDS. 2021. https://www.afro.who.int/health-topics/hivaids. Accessed 15 Mar 2023.
Nguyen TT, Luong AN, Dao TDT, Nagot N, Laureillard D, Visier L, Le MG. What shapes late HIV diagnosis in Vietnam? A qualitative investigation of multilevel factors. AIDS Educ Prev. 2021;33:450–63. https://doi.org/10.1521/aeap.2021.33.5.450.
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1–207.
Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach. Geneva: World Health Organization (2021). http://www.ncbi.nlm.nih.gov/books/NBK572729/ [Accessed June 28, 2023]
Low A, Gavriilidis G, Larke N, B-Lajoie M-R, Drouin O, Stover J, Muhe L, Easterbrook P. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62:1595–603. https://doi.org/10.1093/cid/ciw125.
Article PubMed PubMed Central Google Scholar
Gilbert L, Dear N, Esber A, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Crowell TA, Polyak CS, et al. Prevalence and risk factors associated with HIV and syphilis co-infection in the African Cohort Study: a cross-sectional study. BMC Infect Dis. 2021;21:1123. https://doi.org/10.1186/s12879-021-06668-6.
Article PubMed PubMed Central Google Scholar
Brignol S, Dourado I, Amorim LD, Kerr LRFS. Vulnerability in the context of HIV and syphilis infection in a population of men who have sex with men (MSM) in Salvador, Bahia State. Brazil Cad Saude Publica. 2015;31:1035–48. https://doi.org/10.1590/0102-311X00178313.
Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93:S3–15. https://doi.org/10.1136/sextrans-2016-053069.
Fan L, Yu A, Zhang D, Wang Z, Ma P. Consequences of HIV/syphilis co-infection on HIV viral load and immune response to antiretroviral therapy. Infect Drug Resist. 2021;14:2851–62. https://doi.org/10.2147/IDR.S320648.
Article PubMed PubMed Central Google Scholar
Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford D, Gelman B, McArthur J, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013;24:351–5. https://doi.org/10.1177/0956462412472827.
Article CAS PubMed PubMed Central Google Scholar
Kojima N, Klausner JD. An update on the global epidemiology of syphilis. Curr Epidemiol Rep. 2018;5:24–38. https://doi.org/10.1007/s40471-018-0138-z.
Article PubMed PubMed Central Google Scholar
Hamada Y, Getahun H, Tadesse BT, Ford N. HIV-associated tuberculosis. Int J STD AIDS. 2021;32:780–90. https://doi.org/10.1177/0956462421992257.
Article CAS PubMed PubMed Central Google Scholar
Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29:1987–2002. https://doi.org/10.1097/QAD.0000000000000802.
Hamilton DO, Nunes JV, Grobusch MP. Improving the diagnostics of tuberculosis and drug resistance with Xpert MTB/RIF in a district general hospital in Sierra Leone: a quality improvement project. BMJ Open Qual. 2019;8:e000478. https://doi.org/10.1136/bmjoq-2018-000478.
Article PubMed PubMed Central Google Scholar
Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D. Implementation of Xpert MTB/RIF in Uganda: missed opportunities to improve diagnosis of tuberculosis. Open Forum Infect Dis. 2016;3:ofw068. https://doi.org/10.1093/ofid/ofw068.
Article PubMed PubMed Central Google Scholar
Hoang TTT, Nguyen NV, Dinh SN, Nguyen HB, Cobelens F, Thwaites G, Nguyen HT, Nguyen AT, Wright P, Wertheim HFL. Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam. BMC Public Health. 2015;15:980. https://doi.org/10.1186/s12889-015-2338-5.
Article CAS PubMed PubMed Central Google Scholar
Churchyard GJ, Stevens WS, Mametja LD, McCarthy KM, Chihota V, Nicol MP, Erasmus LK, Ndjeka NO, Mvusi L, Vassall A, et al. Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF. Lancet Glob Health. 2015;3:e450–7. https://doi.org/10.1016/S2214-109X(15)00100-X.
Brown S, Leavy JE, Jancey J. Implementation of GeneXpert for TB testing in low- and middle-income countries: a systematic review. Glob Health Sci Pract. 2021;9:698–710. https://doi.org/10.9745/GHSP-D-21-00121.
Article PubMed PubMed Central Google Scholar
Stosic M, Vukovic D, Babic D, Antonijevic G, Foley KL, Vujcic I, Grujicic SS. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study. BMC Public Health. 2018;18:1114. https://doi.org/10.1186/s12889-018-6021-5.
Article PubMed PubMed Central Google Scholar
Fang X-H, Dan Y-L, Liu J, Jun L, Zhang Z-P, Kan X-H, Ma D-C, Wu G-C. Factors influencing completion of treatment among pulmonary tuberculosis patients. Patient Prefer Adherence. 2019;13:491–6. https://doi.org/10.2147/PPA.S198007.
Article PubMed PubMed Central Google Scholar
Izudi J, Tamwesigire IK, Bajunirwe F. Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study. BMC Public Health. 2020;20:501. https://doi.org/10.1186/s12889-020-08646-0.
Article PubMed PubMed Central Google Scholar
Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west Ethiopia. N Am J Med Sci. 2012;4:67–71. https://doi.org/10.4103/1947-2714.93376.
Article PubMed PubMed Central Google Scholar
World Health Organization. Rapid communication on updated guidance on the management of tuberculosis in children and adolescents. https://www.who.int/publications-detail-redirect/9789240033450 [Accessed June 28, 2023]
World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-susceptible tuberculosis treatment. Geneva: World Health Organization. https://www.who.int/publications-detail-redirect/9789240048126 [Accessed June 28, 2023]
Dian S, Ganiem AR, Ekawardhani S. Cerebral toxoplasmosis in HIV-infected patients: a review. Pathog Glob Health. 2023;117:14–23. https://doi.org/10.1080/20477724.2022.2083977.
Article CAS PubMed Google Scholar
Wang Z-D, Wang S-C, Liu H-H, Ma H-Y, Li Z-Y, Wei F, Zhu X-Q, Liu Q. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4:e177–88. https://doi.org/10.1016/S2352-3018(17)30005-X.
Ducrocq J, Simon A, Lemire M, De Serres G, Lévesque B. Exposure to Toxoplasma gondii through consumption of raw or undercooked meat: a systematic review and meta-analysis. Vector Borne Zoonotic Dis. 2021;21:40–9. https://doi.org/10.1089/vbz.2020.2639.
Rostami A, Riahi SM, Abdollahzadeh Sagha S, Taghipour A, Sepidarkish M, Mohammadnia-Afrouzi M, Ebrahimpour S, Hotez PJ, Gamble R, Gasser RB. Seroprevalence estimates of latent and acute toxoplasma infections in HIV+ people-call for action in underprivileged communities. Microorganisms. 2021;9:2034. https://doi.org/10.3390/microorganisms9102034.
留言 (0)